Completed PHASE1 NCT00005569

Effects of Topical SLPI on Skin Wounds

Effects of Topical Anti-Inflammatory Agents on Cutaneous Wound Healing

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Interventions SLPI (Secretory Leukocyte Protease Inhibitor)

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Apr 30, 2000 Completion: Jul 31, 2003

A PHASE1 clinical study on Healthy and Wound Healing, this trial is completed. The trial is conducted by National Institute of Dental and Craniofacial Research (NIDCR) and has accumulated 5 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Dental and Craniofacial Research (NIDCR)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States